Patients with HE often exhibit elevated levels of anti-thyroid antibodies, including anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies, which can cross-react with brain structures, leading to cognitive impairment and a range of neuropsychiatric manifestations (Churilov et al., 2019). This evidence concerns the gene TPO and Cognitive impairment.